Literature DB >> 17433020

Left atrial volume: a novel predictor of hepatopulmonary syndrome.

Mahmood Zamirian1, Amir Aslani, Shahab Shahrzad.   

Abstract

OBJECTIVES: We studied patients with hepato-pulmonary syndrome (HPS). We found that HPS is frequently present in patients with left atrial enlargement. The aim of this prospective study was to evaluate the possible correlation between left atrial volume and HPS.
METHODS: Adult patients (>18 yr old) with biopsy proven liver cirrhosis who were referred for liver transplantation were enrolled in the study. Diagnosis of HPS was established when the following points were fulfilled: (a) the presence of chronic liver disease, (b) increased alveolar-arterial difference (AaDO(2)), (c) intrapulmonary vascular dilatation, and (d) absence of primary cardiac or pulmonary disease.
RESULTS: We enrolled 41 patients (mean age 47.1 +/- 10.6 yr) diagnosed with HPS. Also 108 Child-Pugh score matched cirrhotic patients (mean age 49.2 +/- 9.3 yr) who have negative contrast echocardiography and normal age-related AaDO(2) were selected as a control group for the purpose of comparison of left atrial volume (LAV). LAV was significantly greater in patients with HPS compared to the control group (55.1 +/- 7.5 mL vs 37.1 +/- 9.3 mL, P < 0.05). The area under the receiver-operating characteristic (ROC) curve for LAV was 0.903 (Cut point >/= 50 mL, sensitivity 86.3%, specificity 81.2%).
CONCLUSION: In the context of liver cirrhosis, LAV >/= 50 mL is a simple and feasible parameter to detect HPS.

Entities:  

Mesh:

Year:  2007        PMID: 17433020     DOI: 10.1111/j.1572-0241.2007.01228.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

Review 1.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

2.  Paradoxical emboli secondary to hepatic pathology: common or coincidental?

Authors:  Patrik Gabikian; Melanie Walker; Abhineet M Chowdhary; Arthur M Lam; Gavin W Britz
Journal:  Case Rep Med       Date:  2009-11-22

3.  Pulmonary vascular complications in asymptomatic children with portal hypertension.

Authors:  John R Whitworth; D Dunbar Ivy; Jane Gralla; Michael R Narkewicz; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-11       Impact factor: 2.839

4.  Liver cirrhosis prevents atrial fibrillation: A reality or just an illusion?

Authors:  Mahmood Zamirian; Tahmineh Sarmadi; Kamran Aghasadeghi; Mohammad Bagher Sharif Kazemi
Journal:  J Cardiovasc Dis Res       Date:  2012-04

5.  Management of cardiopulmonary complications of cirrhosis.

Authors:  Prabha Sawant; C Vashishtha; M Nasa
Journal:  Int J Hepatol       Date:  2011-07-19

Review 6.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

Review 7.  Pulmonary manifestations of chronic liver disease: a comprehensive review.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2020-03-27

Review 8.  Current concepts in the management of hepatopulmonary syndrome.

Authors:  Vincent Ho
Journal:  Vasc Health Risk Manag       Date:  2008

Review 9.  Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature.

Authors:  Caglar Cosarderelioglu; Arif M Cosar; Merve Gurakar; Nabil N Dagher; Ahmet Gurakar
Journal:  J Clin Transl Hepatol       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.